87 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
) (a) words of any gender include each other gender and neuter form; (b) words using the singular or plural number also include the plural or singular … in this Agreement to any gender include references to all genders, and references to the singular include references to the plural and vice versa. Unless
8-K
EX-10.1
7k42r3y ukdtw
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
avjqhp2b
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.4
ua98kkfi94
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
4ojicp
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
66zf wngt
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.3
lyib9vnte
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.4
k1r7y
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
b2h0j6n
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
bvx3f2ahid5vkynm
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-2.1
yd8um7zo2ikcri
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
0zf50rx
10 Aug 20
Tender and Support Agreement
9:48pm
DEFA14A
gwmjd4ww4g4kii5a
4 Jun 19
Additional proxy soliciting materials
5:07pm
8-K
EX-10.1
ou1g jmwwbjqvvjhz
9 Aug 18
Entry into a Material Definitive Agreement
9:05am